Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis.

Baumann LS, Halem ML.

Arch Dermatol. 2003 Feb;139(2):226-7. No abstract available.

PMID:
12588237
2.

Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.

Frasson E, Brigo F, Acler M, Didonè G, Vicentini S, Bertolasi L.

Arch Dermatol. 2011 Jan;147(1):122-3. doi: 10.1001/archdermatol.2010.408. No abstract available.

PMID:
21242408
3.

Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.

Baumann L, Slezinger A, Halem M, Vujevich J, Martin LK, Black L, Bryde J.

Int J Dermatol. 2005 May;44(5):418-24.

PMID:
15869543
4.

Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.

Rosell K, Hymnelius K, Swartling C.

Acta Derm Venereol. 2013 May;93(3):335-9. doi: 10.2340/00015555-1464.

5.

Writer's block: "texting" impairment as a complication of botulinum toxin type A therapy for palmar hyperhidrosis.

Lehman JS.

Arch Dermatol. 2011 Jun;147(6):752. doi: 10.1001/archdermatol.2011.143. No abstract available.

PMID:
21690551
6.

Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.

Chapman MA, Barron R, Tanis DC, Gill CE, Charles PD.

Clin Ther. 2007 Jul;29(7):1325-37. Review.

PMID:
17825685
7.

The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.

Glaser DA.

Neurotox Res. 2006 Apr;9(2-3):173-7. Review.

PMID:
16785115
8.

Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.

Glogau RG.

Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S191-7. Review.

PMID:
12569968
9.

Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients.

Lecouflet M, Leux C, Fenot M, CĂ©lerier P, Maillard H.

J Am Acad Dermatol. 2014 Jun;70(6):1083-7. doi: 10.1016/j.jaad.2013.12.035.

PMID:
24630001
10.

Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented?

Kouris A, Vavouli C, Markantoni V, Kontochristopoulos G.

J Drugs Dermatol. 2014 Nov;13(11):1315-6.

PMID:
25607695
11.

Autonomic side effects of botulinum toxin type B therapy.

Dressler D, Benecke R.

Adv Neurol. 2004;94:315-20. No abstract available.

PMID:
14509689
12.

Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.

Baumann L, Slezinger A, Halem M, Vujevich J, Mallin K, Charles C, Martin LK, Black L, Bryde J.

Dermatol Surg. 2005 Mar;31(3):263-70.

PMID:
15841624
13.

Relapsing-remitting severe generalized muscular weakness after botulinum toxin treatment for hyperhidrosis.

Chiarello D, Piombo M, Corbetto M, Di Pino G, Assenza G, Capone F, Di Lazzaro V.

Muscle Nerve. 2014 Sep;50(3):456-7. doi: 10.1002/mus.24304. No abstract available.

PMID:
24890202
14.

Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.

Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, Ganzetti G, Offidani A.

J Eur Acad Dermatol Venereol. 2011 Aug;25(8):917-21. doi: 10.1111/j.1468-3083.2010.03880.x.

PMID:
21054569
15.

Treatment of compensatory hyperhidrosis with botulinum toxin type A.

Belin EE, Polo J.

Cutis. 2003 Jan;71(1):68-70.

PMID:
12553633
16.

Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.

Wynn RL.

Gen Dent. 2011 Mar-Apr;59(2):88-90. No abstract available.

PMID:
21903516
17.

Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.

Muller F, Cugy E, Ducerf C, Delleci C, Guehl D, Joseph PA, Burbaud P, Dehail P.

Clin Rehabil. 2012 Feb;26(2):174-9. doi: 10.1177/0269215511412799.

PMID:
21937525
18.

Bilateral forearm intravenous regional anesthesia with prilocaine for botulinum toxin treatment of palmar hyperhidrosis.

Bosdotter Enroth S, Rystedt A, Covaciu L, Hymnelius K, Rystedt E, Nyberg R, Naver H, Swartling C.

J Am Acad Dermatol. 2010 Sep;63(3):466-74. doi: 10.1016/j.jaad.2009.10.034.

PMID:
20708471
19.

The place of botulinum toxin type A in the treatment of focal hyperhidrosis.

Lowe N, Campanati A, Bodokh I, Cliff S, Jaen P, Kreyden O, Naumann M, Offidani A, Vadoud J, Hamm H.

Br J Dermatol. 2004 Dec;151(6):1115-22. Review.

PMID:
15606505
20.

How to save botulinum toxin A in the treatment of focal axillary hyperhidrosis.

Bechara FG, Sand M, Hoffmann K.

Dermatology. 2006;213(4):356. No abstract available.

PMID:
17135747
Items per page

Supplemental Content

Support Center